Evidence for joint action of genes on diabetes status and cvd risk factors in american indians: The strong heart family study

International Journal of Obesity

Volumn 27, Issue 4, 2003, Pages 491-497

  North, K E ^a   Williams, J T ^b   Welty, T K ^c   Best, L G ^d   Lee, E T ^e   Fabsitz, R R ^f   Howard, B V ^g   MacCluer, J W ^b  

^a IL   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c Aberdeen Area Tribal Chairmen's Health Board   (United States)

^d MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

American Indians; CVD risk factors; Diabetes status; Pleiotropy; Strong heart family study

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT;

APSEUDES;

EID: 0037396444     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802261     Document Type: Article

References (77)

1. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complicat 2001; 15: 44-54.
2. Galloway JM, Alpert JS. Coronary artery, disease and hypertension. In: Galloway JM, Goldberg BW, Alpert JS (eds). Primary care of Native American patients: diagnosis, therapy, and epidemiology. Woburn, MA: Butterwoth-Heinemann, 1999, pp 125-131.
3. Welty TK, Rhoades D, Lee ET, Yeh F, Cowan LD, Fabsitz R, Robbins DC, Devereux RB, Henderson JA, Crawford AS, Howard BV. Changes in cardiovascular risk factors among American Indians: the strong heart study. Ann Epidemiol 2002; 12: 97-106.
4. Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go OT, Howard BV. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-88: the strong heart study. Am J Epidemiol 1998; 147: 995-1008.
5. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK. Rising tide of cardiovascular disease in American Indians. The strong heart study. Circulation 1999; 99: 2389-2395.
6. North KE, Howard BV, Best L, Lee ET, Fabsitz RR, MacCluer JW. Genetic and environmental contributions to cardiovascular disease risk factors in American Indians: the strong heart family study. Am J Epidemiol 157: 303-314.
7. North KE, MacCluer JW, Best L, Welty TK, Lee ET, Fabsitz RR, Howard BV. Evidence for distinct genetic effects on obesity and lipid related CVD risk factors in diabetic and non-diabetic American Indians: the strong heart family study. Diabetes Metab Res Rev 2003, (in press).
8. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP. Linkage of type 2 diabetes mellitus and age on onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999; 64: 1127-1140.
9. Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopik AJ, Yeh J, Go O, Robbins DC, Welty TK. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. Diabetes Care 1995; 18: 599-610.
10. Diehl AK, Stern MP. Special health problems of Mexican Americans: obesity, gallbladder disease, diabetes mellitus, and cardiovascular disease. Adv Intern Med 1989; 34: 73-96.
11. Chakraborty R, Ferrell RE, Stern MP, Haffner SM, Hazuda HP, Rosenthal M. Relationship of prevalence of non-insulin dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas. Genet Epidemiol 1986; 3: 435-454.
12. Brosseau JD, Eelkema RC, Crawford AC, Abe TA. Diabetes among the three affiliated tribes: correlations with degree of Indian inheritance. Am J Public Health 1979; 69: 1277-1278.
13. 3,5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet 1988; 43: 520-526.
14. Barnett AH, Eff C, Lesline RDG, Pyke AA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87-93.
15. Newman B, Sekby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type II (NIDDM) in male twins. Diabetologia 1987; 30: 763-768.
16. Kaprio J, Tuomilehto J, Koskenvou M. Concordance for type 1 (insulin dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 30: 763-768.
17. Rewers M, Hamman RF. Risk factors for NIDDM. National Diabetes Data Group. Diabetes in America, 2nd edn. National Institutes of Health, National institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. NIH Publication no. 95-1468; 1995.
18. Knowler WC, Pettitt DL, Savage PJ, Bennett PH. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetics. Am J Epidemiol 1981; 113: 144-156.
19. Lee ET, Anderson PS, Bryan J. Diabetes, parental diabetes, and obesity in Oklahoma Indians. Diabetes Care 1985; 8: 107-113.
20. Warfare JH, Martin BC, Soeldner JS, Krolewski AS. Study of glucose removal rate and first phase insulin secretion in the offspring of two parents with NIDDM. In: Camerini-Davalos RA, Cole HS (eds). Adv Exp Med Biol 1988; 246: 175-183.
21. Hsueh W, Mitchell BD, Aburomia R, Pollin T, Sakul H, Ehm MG, Michelsen BK, Wagner MJ, St Jean PL, Knowler WC, Burns DK, Bell CJ, Shuldiner AR. Diabetes in the old order Amish. Characterization and heritability analysis of the Amish Diabetes Study. Diabetes Care 2000; 23: 595-601.
22. Duggirala R, Williams JT, Williams-Blangero S, Blangero J. A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 1997; 14: 987-992.
23. Williams JT, Van Eerdewegh P, Almasy L, Blangero J. Joint multipoint analysis of multivariate qualitative and quantitative traits. I. Likelihood formation and simulation results. Am J Hum Genet 1999; 65: 1134-1147.
24. Lee ET, Welty TK, Fabsitz RR, Cowan LD, Le N, Oopik AV, Cucchiara AJ, Savage PJ, Howard BV. The Strong Heart Study A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990; 132: 1141-1155.
25. Howard BV, Lee ET, Cowan L, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK. Coronary heart disease prevalence and its relation to heart disease in American Indians: the Strong Heart Study. Am J Epidemiol 1995; 142: 254-268.
26. Liedtke RJ. Principles of bioelectric independence analysis. 1997, www.rjlsystems.com/research/bia-principles.html.
27. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, Yeh J, Savage PJ, Lee ET. Risk factors for coronary heart disease in diabetic and non-diabetic Native Americans: The Strong Heart Study. Diabetes 1992; 41(Suppl 2): 4-11.
28. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
29. Geffken D, Keating h Kennedy M, Cornell E, Bovill E, Tracy R. The measurement of fibrinogen in population-based research: Studies on instrumentation and methodology. Arch Pathol Lab Med 1994; 118: 1106-1109.
30. DeClerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague 1. Measurement of plasminogen activator inhibitor 1 in biological fluids with a routine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-225.
31. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998; 15: 539-553.
32. Falconer DS. Introduction to quantitative genetics, 3rd edn.: Long-man Essex, UK; 1989.
33. Hopper JL, Mathews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982; 46: 373-383.
34. Lange K, Boehnke M. Extensions to pedigree analysis IV. Covariance components models for multivariate traits. Am J Med Genet 1983; 35: 816-826.
35. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J of Hum Genet 1994; 54: 535-543.
36. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
37. Self SG, Liang KY. Asymptotic properties of maximum likelihood ratio tests under nonstandard conditions. J Am Statist Assoc 1987; 82: 605-610.
38. Blangero J, Williams JT, Almasy L. Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol 2000; 19(Suppl 1): S8-514.
39. Bjorntorp P, Rosmond R. Visceral obesity and diabetes. Drugs Suppl 1999; 1: 13-18.
40. Seidell JC. Obesity, insulin resistance and diabetes a worldwide epidemic. Br J Nutr 2000; 83(Suppl 1): S5-58.
41. Reaven GM. Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 1987; 36:(Suppl 1): 1-8.
42. Howard BV, Howard WJ. Dyslipidemia in non-insulin-dependent diabetes mellitus. Endocrine Rev 1994; 15: 263-274.
43. Larsen JL. Dyslipidemia in diabetes: a comprehensive analysis. Adv Nurse Pract 1998; 6: 36-43.
44. Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: 160-178.
45. Fujii S, Goto D, Zaman T, Ishimori N, Watano K, Kaneko T, Okada H, Makiguchi M, Nakagawa T, Kitabatake A. Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis. J Atheroscler Thromb 1998; 5: 76-81.
46. Bastard JP, Pieroni L, Hainque B. Relationship between plasma plasminogen activator inhibitor i and insulin resistance. Diabetes Metab Res Rev 2000; 16: 192-201.
47. Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney diseases in obesity. Ann NY Acad Sci 1999; 892: 91-107.
48. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
49. Despres JP, Lamarche B, Mauriege P, Cantin B, Lupien PJ, Dagena GR. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
50. Mitchell BD, Kammerer CK, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD, Haffner SM, Stern MP, MacCluer JW. Genetic analysis of the IRS pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 1996; 16: 281-288.
51. Carmelli, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: Same genes or same environments? Am J Hum Genet 1994; 55: 566-573.
52. Edwards KL, Newman B, Mayer E, Selby JV, Krauss RM, Austin MA. Heritability of factors of the insulin resistance syndrome in women twins. Genet Epidiol 1997; 14: 241-253.
53. Duggirala R, Williams K, Arya R, Blangero J, Stern MP. Genetic factors underlying the Insulin Resistance Syndrome in nondiabetic Mexican Americans. Am J Hum Biol 2000; 12: 274.
54. Mahaney MC, Blangero J, Comuzzie AG, Van de Berg JL, Stern MP, MacCluer JW. Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative test of the cojoint trait hypothesis in the San Antonio Family Heart Study. Circulation 1995; 92: 3240-3248.
55. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
56. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and overall obesity in a general population. Atherosclerosis risk in communities study investigators. Metabolism 1996; 45: 699-706.
57. Garvey WT, Hermayer KL. Clinical implications of the insulin resistance syndrome. Clin Cornerstone 1998; 1: 13-28.
58. Tenkanen L, Manttari M, Manninen V. Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study. Circulation 1995; 92: 1779-1785.
59. Stec JJ, Silberashatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PFW, Muller JE, D'Agostino RB. Association of fibrinogen with cardiovascular disease risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102: 1634-1638.
60. Lam TH, Liu LJ, Janus ED, Lam KS, Hedley AJ. Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Med 2000; 17: 798-806.
61. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarro ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipolniacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233-3240.
62. MacAuley D, McCrumm EE, Stott G, Evans AE, Duly E, Trinick T, Sweeney K, Boreham CA. Physical activity, lipids, apolipoproteins, and Lp(a) in the Northern Ireland Health and Activity Survey. Med Sci Sports Exerc 1996; 28: 720-736.
63. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 1998; 19(Suppl A): A53-A61.
64. Haffner SM. Diabetes, hyperlipidemia, and coronary artery disease. Am J Cardiol 1999; 83: 17F-21F.
65. Wagner AM, Perez A, Calvo F, Bonet R, Castellvi A, Ordonez, J. Apolipoprotein (B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetes patients. Diabetes Care 1999; 22: 812-817.
66. Luc G, Bard J, Evans A, Arveiler D, Ruidavets J, Amouyel P, Ducimetiere P. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the PRIME Study. Atherosclerosis 2000; 152: 399-405.
67. Imamura H, Uchida K, Kobata D. Relationship of cigarette smoking with blood pressure, serum lipids, and lipoproteins in young Japanese women. Clin Exp Pharmacol Physiol 2000; 27: 364-369.
68. Tuut M, Hense H. Smoking, other risk factors and fibrinogen levels. Evidence of effect modification. Ann Epidemiol 2001; 11: 232-238.
69. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J 1999; 319: 1523-1528.
70. Mennen LI, Balkau B, Vol S, Caces E, Eshwege E. Fibrinogen: a possible link between alcohol consumption and cardiovascular disease. Arterioscler Thromb Vasc Biol 1999; 19: 887-892.
71. James S, Vorster HH, Venter CS, Kruger HS, Nell TA, Veldman FJ, Ubbink JB. Nutritional status influences plasma fibrinogen concentration: Evidence from the THUSA Survey. Thromb Res 2000; 98: 383-394.
72. Di Minno G, Piemontino U, Cerbone AM. Nutrition and thrombogenic factors. Nutr Metab Cardiovasc Dis 1999; 9 (4 Suppl): 16-20.
73. Koenig W, Ernst E. Exercise and thrombosis. Coronary Artery Dis 2000; 11: 123-127.
74. Vanninen E, Laitinen J, Uusitupa M. Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care 1994; 17: 1031-1038.
75. Lee ET, Welty TK, Cowan LD, Rhoades DA, Devereux R, Go O, Fabsitz R, Wang W, Howard BV. Incidence of diabetes mellitus in American Indians of three geographic areas: the Strong Heart Study. Diabetes Care 2002; 25: 49-54.
76. Yurgalevitch SM, Kriska AM, Welty TK, Go O, Robbins DC, Howard BV. Physical activity and lipids and lipoproteins in American Indians ages 45-74. Med Sci Sports Exerc 1998; 30: 543-549.
77. Wallenstein S, Zucker C, Fleiss J. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1-9.